Schamroth Michael 4
4 · BIOSPECIFICS TECHNOLOGIES CORP · Filed Sep 6, 2019
Insider Transaction Report
Form 4
Schamroth Michael
Director
Transactions
- Exercise/Conversion
Common Stock, $0.001 par value
2019-09-03$26.43/sh+15,000$396,450→ 115,890 total - Exercise/Conversion
StoStock Option (right to buy)
2019-09-03−15,000→ 0 totalExercise: $26.43Exp: 2019-09-07→ Common Stock (15,000 underlying)
Footnotes (1)
- [F1]The option vested in full on September 8, 2009.